Histone methyltransferase SMYD3 methylates MAP3K2 at lysine 260 that blocks PP2A interaction in KRAS mutant PDAC and NSCLC cells, followed by activation of MAPK signaling 97. This evidence concerns the gene PTPA and non-small cell lung carcinoma.